Larkspur Health LLC - 06 Jan 2022 Form 4 Insider Report for Larkspur Health Acquisition Corp. (ZVSA)

Role: 10%+ Owner
Signature: /s/ Daniel O'Connor, Managing Member
Issuer symbol: ZVSA
Transactions as of: 06 Jan 2022
Net transactions value: $0
Form type: 4
Filing time: 10 Mar 2022, 16:32:48 UTC
Previous filing: 10 Mar 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ZVSA	Class A Common Stock	Other	$0	+236,273		$0.000000	236,273	06 Jan 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ZVSA	Class B Common Stock	Other	$0	+3,427	+0.3%	$0.000000	1,141,326	06 Jan 2022	Class A Common Stock	3,427		Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares are underlying units (each unit consisting of one share of Class A common stock and three-fourths of one warrant, each whole warrant exercisable to purchase one share of Class A common stock) acquired in a private placement by the Reporting Person in connection with the issuer's initial public offering and subsequent partial exercise of the underwriters' over-allotment option. The above refers to the shares of Class A common stock included in the units purchased.
F2	As described in the issuer's registration statement on Form S-1 (File No. 333-256056) (the "Registration Statement") under the section entitled "Description of Securities - Founder Shares," the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date
F3	In connection with the partial exercise of the underwriters' over-allotment option, A.G.P./Alliance Global Partners transferred 3,427 shares to the reporting person for no consideration.